Skip to main content
Skip to section navigation
Skip to footer
Home
Our story
Our focus
Our portfolio
Pipeline
REL-1017
EAP
Data and publications
For investors
Company
Stock
SEC filings
Governance
Analysts
News
Events
Contact us
Sign up for email alerts
Contact us
For investors
For investors
Company
Stock
SEC filings
Governance
Analysts
News
Events
Relmada Therapeutics, Inc.
Events
Q4 & FY 2021 Financial Results Conference Call
Mar 23, 2022 4:30 PM EDT
Webcast
Audio
